Johns Hopkins ABX Guide
Dapsone
INDICATIONS
FDA
FDA
- Leprosy
- Dermatitis herpetiformis
- Acne vulgaris (dapsone 7.5% or 5% gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Aphthous ulcers, severe
- Bullous SLE
- Chronic spontaneous urticaria
- ITP
- PCP prophylaxis
- Pemphigus vulgaris
- Pyoderma gangrenosum
- Relapsing polychondritis
- PCP (with trimethoprim)
- Treatment of mild to moderately severe PCP
- Toxoplasmosis prophylaxis (with pyrimethamine and leucovorin) in patients with HIV
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 16, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Dapsone." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540154/7/Dapsone.
Auwaerter PG, Pham PA. Dapsone. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540154/7/Dapsone. Accessed October 30, 2025.
Auwaerter, P. G., & Pham, P. A. (2023). Dapsone. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540154/7/Dapsone
Auwaerter PG, Pham PA. Dapsone [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2025 October 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540154/7/Dapsone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dapsone
ID - 540154
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2023/07/16/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540154/7/Dapsone
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
